Controlled Substances Act
(Redirected from Schedule I drug)
United States federal drug policy law
The Controlled Substances Act (CSA) is a United States federal law that regulates the manufacture, importation, possession, use, and distribution of certain substances. The CSA was enacted into law by the 91st United States Congress as Title II of the Comprehensive Drug Abuse Prevention and Control Act of 1970.
Overview
The Controlled Substances Act provides the legal framework for the regulation of drugs and other substances that are subject to abuse. It classifies drugs into five schedules based on their potential for abuse, accepted medical use, and safety or dependence liability. The Drug Enforcement Administration (DEA) is the federal agency responsible for enforcing the CSA.
Schedules of Controlled Substances
The CSA categorizes substances into five schedules:
- Schedule I: Substances with a high potential for abuse, no accepted medical use, and a lack of accepted safety for use under medical supervision. Examples include heroin, LSD, and cannabis.
- Schedule II: Substances with a high potential for abuse, with use potentially leading to severe psychological or physical dependence, but with accepted medical uses. Examples include cocaine, methamphetamine, and oxycodone.
- Schedule III: Substances with a moderate to low potential for physical and psychological dependence. Examples include anabolic steroids, testosterone, and products containing less than 90 milligrams of codeine per dosage unit.
- Schedule IV: Substances with a low potential for abuse and low risk of dependence. Examples include alprazolam, diazepam, and lorazepam.
- Schedule V: Substances with lower potential for abuse than Schedule IV and consist of preparations containing limited quantities of certain narcotics. Examples include cough preparations containing less than 200 milligrams of codeine per 100 milliliters or per 100 grams.
Regulatory Framework
The CSA establishes a closed system of distribution for controlled substances, which means that only those registered with the DEA may legally handle these substances. This includes manufacturers, distributors, pharmacies, and healthcare providers. The Act also sets forth the requirements for recordkeeping, security, and reporting to prevent diversion and misuse.
Amendments and Impact
Since its enactment, the CSA has been amended several times to address emerging drug abuse issues and to update the scheduling of substances. The Act has had a significant impact on drug policy in the United States, influencing both domestic and international drug control efforts.
Criticism and Controversy
The CSA has faced criticism for its classification of certain substances, particularly cannabis, as Schedule I, despite evidence of medical benefits. Critics argue that the scheduling system can hinder research and access to potentially beneficial treatments.
Related pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD